Renasant Corp

RNST remains in a Stage 2 uptrend characterized by higher highs and lows, but the recent Bullish Exhaustion signal highlights near-term buyer fatigue. Price is currently pulling back into the rising 9/20 EMA support zone, offering a favorable entry point. Medium-term momentum remains intact, and buying now near short-term EMA support aligns with continuation participation. A sustained break below the 50-day SMA would invalidate this bullish bias.

• ↑Adjusted EPS rose 36% YoY to $0.94 in Q2 2026.
• ↑Efficiency ratio improved to 57.9% from 67.6% YoY.
• ↓Negative profitability and revision momentum indicate margin pressure.